Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
University Medical Center Utrecht
Utrecht, HolandaPublicacións en colaboración con investigadores/as de University Medical Center Utrecht (52)
2024
-
Neddylation orchestrates the complex transcriptional and posttranscriptional program that drives Schwann cell myelination
Science Advances, Vol. 10, Núm. 15
-
Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
European Journal of Nuclear Medicine and Molecular Imaging
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Biofunctionalization of 3D printed collagen with bevacizumab-loaded microparticles targeting pathological angiogenesis
Journal of Controlled Release, Vol. 360, pp. 747-758
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
EANM position paper: theranostics in brain tumours—the present and the future
European Journal of Nuclear Medicine and Molecular Imaging
-
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Psychiatry Research, Vol. 323
-
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
European Journal of Nuclear Medicine and Molecular Imaging
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
2022
-
A replication study of JTC bias, genetic liability for psychosis and delusional ideation
Psychological Medicine, Vol. 52, Núm. 9, pp. 1777-1783
-
Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)
Nature Communications
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway
Psychological Medicine, Vol. 52, Núm. 10, pp. 1910-1922
-
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
European Neuropsychopharmacology, Vol. 63, pp. 47-59
2021
-
Breast cancer risk genes - Association analysis in more than 113,000 women
New England Journal of Medicine, Vol. 384, Núm. 5, pp. 428-439